Skip to main content
Health Podcast Library

Risky Business: PD-1 Immune Checkpoint Blockade in Thymic Epithelial Neoplasms

Journal of Clinical Oncology (JCO) Podcast · 9 min

Episode Description

This podcast discusses the important risks and potential benefits of PD-1 immune checkpoint blockade in patients with thymic epithelial neoplasms.

Read the related article "Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial" on JCO.org

Topics

Cancer ImmunotherapyCancer

Listen On

Apple PodcastsSpotify
How to rate & review on Apple Podcasts

Proudly Supported by

Forvis MazarsHeadlinerBetterHelpCalendarPAAAOSmowPod

Patrons of Health Podcast Library

OrthoInfo
AAOS Now Podcast
Achieving Health
AAOS Career Podcast
Who the Health Cares? with Prof Michael Sparer
Aging Like a Pro
Stronger After Stroke

Supporting Shows

Healthcare for Humans
HITea With Grace
HIT Like a Girl Pod: Empowering Women in Health IT
Thriving with Addiction with Dr. Jonathan Avery
Hopeful Hints
Cuts and Consults
Speak Up For Your Health
Nurse Rosa's INsights
Faces of Digital Health
Beyond The Paper Gown Podcast
This Just In Radio Show
Coffee Break: Breaking the Cycle of Bullying in Healthcare, One Cup at a Time
Coaching Healthcare Leaders

We use cookies to run this site. Analytics cookies help us understand how you use it and are off until you say yes. You can change your mind at any time from the privacy preferences icon at the bottom right.We use cookies to run this site and to understand how it's used. You can opt out at any time from the privacy preferences icon at the bottom right. Cookie policy